Möller P - Search Results

1

In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

Sun Y, Möller P, Berking C, Schlüpen EM, Volkenandt M, Schadendorf D. Sun Y, et al. Among authors: moller p. Immunology. 1999 Dec;98(4):535-40. doi: 10.1046/j.1365-2567.1999.00902.x. Immunology. 1999. PMID: 10594685 Free PMC article.

2

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.

Sun Y, Jurgovsky K, Möller P, Alijagic S, Dorbic T, Georgieva J, Wittig B, Schadendorf D. Sun Y, et al. Among authors: moller p. Gene Ther. 1998 Apr;5(4):481-90. doi: 10.1038/sj.gt.3300619. Gene Ther. 1998. PMID: 9614572 Clinical Trial.

3

Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation.

Alijagic S, Möller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D. Alijagic S, et al. Among authors: moller p. Eur J Immunol. 1995 Nov;25(11):3100-7. doi: 10.1002/eji.1830251117. Eur J Immunol. 1995. PMID: 7489749

4

Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cells.

Finke S, Trojaneck B, Möller P, Schadendorf D, Neubauer A, Huhn D, Schmidt-Wolf IG. Finke S, et al. Among authors: moller p. Cancer Gene Ther. 1997 Jul-Aug;4(4):260-8. Cancer Gene Ther. 1997. PMID: 9253512

5

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Möller P, Sun Y, Dorbic T, Alijagic S, Makki A, Jurgovsky K, Schroff M, Henz BM, Wittig B, Schadendorf D. Möller P, et al. Br J Cancer. 1998 Jun;77(11):1907-16. doi: 10.1038/bjc.1998.317. Br J Cancer. 1998. PMID: 9667667 Free PMC article. Clinical Trial.

6

Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.

Möller P, Möller H, Sun Y, Dorbic T, Henz BM, Wittig B, Schadendorf D. Möller P, et al. Among authors: moller h. Cancer Gene Ther. 2000 Jul;7(7):976-84. doi: 10.1038/sj.cgt.7700203. Cancer Gene Ther. 2000. PMID: 10917199 Clinical Trial.

7

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.

Böhm M, Möller P, Kalbfleisch U, Worm M, Czarnetzki BM, Schadendorf D. Böhm M, et al. Among authors: moller p. Br J Cancer. 1994 Jul;70(1):54-9. doi: 10.1038/bjc.1994.249. Br J Cancer. 1994. PMID: 8018541 Free PMC article.

8

Somatic gene therapy and its implications in melanoma treatment.

Möller P, Schadendorf D. Möller P, et al. Arch Dermatol Res. 1997 Jan;289(2):71-7. doi: 10.1007/s004030050157. Arch Dermatol Res. 1997. PMID: 9049039 Review. No abstract available.

9

Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report.

Möller P, Wittig B, Schadendorf D. Möller P, et al. Anticancer Res. 1998 Mar-Apr;18(2B):1237-41. Anticancer Res. 1998. PMID: 9615794

10

[Interleukin 7 in dermatology. Molecular, immunologic and preclinical aspects].

Möller P, Czarnetzki BM, Schadendorf D. Möller P, et al. Hautarzt. 1995 Oct;46(10):676-82. doi: 10.1007/s001050050321. Hautarzt. 1995. PMID: 7499126 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,975 results

Search Page

Filters